is mounjaro a glp-1 receptor agonists GLP-1 Weight Loss Myths: What

Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes

New FDA regulations and legal actions are phasing out compounded GLP-1s, while companies introduce lower-priced, FDA-approved alternatives.

Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline

However, most (59%) of same those employers say their cost for the drugs has exceeded expectations

While nothing works exactlylike Ozempic, there are evidence-backed, natural options that can help regulate blood sugar, supp